Sign Out
Preparation for Administration: 1. Do not shake the content of the vial. A vigorous shaking could denature the protein and affect the biological activity of the product.
2. Product should be inspected visually for particulates and discoloration prior to administration, if these are present do not use the product.
3. Use a sterile syringe and appropriate aseptic technique. Remove the cap from the vial containing Cimaher (Nimotuzumab) and clean the top of the vial with antibacterial solution, and insert the needle into the vial to extract the content.
4. The Cimaher (Nimotuzumab) at the selected dosage should be diluted in 250 ml of sodium chloride 0.9%.
